دكتور. يوجين الأصلي

آخر تحديث: أغسطس 16, 2026

دكتور. Eugene Zadorin is a European physician-scientist, researcher, and entrepreneur with more than 25 years of experience in clinical research, cardiovascular medicine, الطب التجديدي, and biomedical innovation.

His work has focused on translational research, advanced therapeutic technologies, and the development of international scientific and healthcare projects bridging academia, البحوث السريرية, and emerging biotechnology.

Key Areas of Expertise

• Clinical research and translational medicine

• Cardiovascular science and vascular biology

• Regenerative medicine and cell-based technologies

• Biomedical innovation and deep-tech project development

• International scientific collaboration and research management

Education and Academic Background

• Medical Doctor (دكتوراه في الطب), 2000

• PhD in Cardiology, 2005

Scientific Contributions

• Development of diagnostic approaches for primary pulmonary hypertension

• Research on oxidative stress, مسارات أكسيد النيتريك, and vascular function

• Investigation of cellular and regenerative mechanisms relevant to cardiovascular medicine

• Author and co-author of more than 40 scientific publications in peer-reviewed medical journals

Professional Activities

Founder of NBScience, an international organization supporting clinical research, scientific education, and biomedical innovation.

Over the past two decades, دكتور. Zadorin has contributed to numerous international projects in clinical research, الطب التجديدي, and advanced healthcare technologies, working with researchers, المتخصصين في الرعاية الصحية, academic institutions, and biotechnology partners worldwide.

Current Focus

دكتور. Zadorin is currently involved in the development of innovative deep-tech and biomedical projects, fostering collaborations between research institutions, universities, healthcare organizations, وشركاء الصناعة. His work focuses on translating scientific discoveries into practical healthcare and technological solutions while supporting international research and innovation ecosystems.

He remains actively engaged in scientific collaboration, research strategy, and the advancement of next-generation biomedical technologies.